← 產業報告目錄

Patient Support Programs (PSP) Market Size, Share & Trends Analysis Report By Functionality (Communication, Health Tracking & Insights, Billing & Payments, Administrative, Patient Education, Others), By Therapeutic area (Health & Wellness, Chronic Disease Management, Others), By Application, By End-user, By Region, And By Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-17頁數 179報告編號 INSIGHTACE-37d144399f

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

Valued at USD 21.8 Billion as of 2024, the global Patient Support Programs (PSP) Market is set to climb to USD 104.7 Billion by 2034, reflecting a compound annual growth rate of 17.1% over the 2025–2034 period. The Patient Support Programs (PSP) sector involves The patient support programs (PSP) market represents a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to impr. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics. Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Patient Support Programs (PSP) Market Snapshot Chapter 4. Global Patient Support Programs (PSP) Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Functionality Estimates & Trend Analysis 5.1. By Functionality, & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Functionality: 5.2.1. Communication 5.2.2. Health Tracking & Insights 5.2.3. Billing & Payments 5.2.4. Administrative 5.2.5. Patient Education 5.2.6. Others Chapter 6. Market Segmentation 2: By Therapeutic area Estimates & Trend Analysis 6.1. By Therapeutic area & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic area: 6.2.1. Health & Wellness 6.2.2. Chronic Disease Management 6.2.3. Others Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis 7.1. By Application & Market Share, 2024 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application: 7.2.1. Population Health Management 7.2.2. Outpatient Health Management 7.2.3. In-patient Health Management 7.2.4. Others Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis 8.1. By End-user & Market Share, 2024 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user: 8.2.1. Payers 8.2.2. Providers 8.2.3. Others Chapter 9. Patient Support Programs (PSP) Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Functionality, 2021-2034 9.1.2. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Therapeutic area, 2021-2034 9.1.3. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 9.1.4. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034 9.1.5. North America Patient Support Programs (PSP) Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034 9.2.2. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034 9.2.3. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034 9.2.4. Europe Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034 9.2.5. Europe Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, 2021-2034 9.3.2. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, 2021-2034 9.3.3. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By Application, 2021-2034 9.3.4. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, 2021-2034 9.3.5. Asia Pacific Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034 9.4. Latin America 9.4.1. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality, (US$ Million) 2021-2034 9.4.2. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034 9.4.3. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By Application, (US$ Million) 2021-2034 9.4.4. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034 9.4.5. Latin America Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Functionality (US$ Million) 2021-2034 9.5.2. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Therapeutic area, (US$ Million) 2021-2034 9.5.3. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By Application (US$ Million) 2021-2034 9.5.4. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034 9.5.5. Middle East & Africa Patient Support Programs (PSP) Market revenue (US$ Million) by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Allscripts Healthcare, LLC 10.2.2. Orion Health 10.2.3. Cerner Corporation 10.2.4. McKesson Corporation 10.2.5. athenahealth, Inc. 10.2.6. IBM 10.2.7. Medecision 10.2.8. GetWellNetwork, Inc. 10.2.9. MEDHOST 10.2.10. Lincor 10.2.11. IQVIA 10.2.12. Wolters Kluwer N.V. 10.2.13. Force Therapeutics LLC 10.2.14. Quil 10.2.15. Greenway Health, LLC 10.2.16. Mytonomy 10.2.17. Klara Technologies, Inc. 10.2.18. Solutionreach, Inc. 10.2.19. CureMD Healthcare 10.2.20. Patient point LLC 10.2.21. Vivify Health 10.2.22. Nuance Communications, Inc.

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們